文献速递毛发、甲与色素性疾病

PPAR-γ信号保护毛囊干细胞免受化疗诱导的凋亡与上皮-间质转化

Peroxisome proliferator-activated receptor-γ signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial-mesenchymal transition.
PubMed 文献 · Br J Dermatol · 2021-11-24

该研究在体外器官培养的人头皮毛囊中,用环磷酰胺代谢物4-氢过氧环磷酰胺(4-HC)处理,观察到毛囊隆突区K15+上皮毛囊干细胞发生凋亡、p53上调、DNA损伤及病理性上皮-间质转化(EMT)。预先使用PPAR-γ激动剂NAGED可减轻上述损伤并防止K15+干细胞耗竭,提示激活PPAR-γ信号是预防永久性化疗性脱发(pCIA)的新策略。

要点

  • 环磷酰胺代谢物4-HC可诱导人毛囊隆突K15+干细胞凋亡、DNA损伤和EMT。
  • PPAR-γ激动剂NAGED预处理可减轻4-HC所致毛球细胞毒性与干细胞耗竭。
  • 激活PPAR-γ信号可能成为预防永久性化疗性脱发的干预方向。

核心结论

  • 环磷酰胺代谢物单独即可通过促进凋亡、DNA损伤和EMT损伤并耗竭人头皮上皮毛囊干细胞,预防pCIA需靶向这些病理机制。
  • NAGED在体外能防止化疗诱导的毛囊干细胞损伤,提示刺激PPAR-γ信号是预防pCIA的新干预策略。

研究设计与样本

  • 研究采用体外器官培养的人头皮毛囊,分别用环磷酰胺代谢物4-HC处理,以及先用PPAR-γ激动剂NAGED预处理后再用4-HC处理。
  • 原文摘要未报告样本量、分组数量及统计学数值。

主要发现

  • 4-HC处理引起毛球细胞毒性、毛囊营养不良和退行期诱导,并伴随凋亡、p53表达升高和DNA损伤。
  • 4-HC在K15+上皮毛囊干细胞中引起病理性EMT,表现为E-钙黏蛋白表达下降及毛囊隆突区出现纤连蛋白+和波形蛋白+细胞。
  • NAGED预处理可防止4-HC诱导的毛球细胞毒性/营养不良,以及隆突区凋亡、p53上调和EMT,显著防止K15+人上皮毛囊干细胞耗竭。

临床怎么用

  • 对接受环磷酰胺类化疗的患者,可关注毛囊干细胞凋亡与EMT作为pCIA的潜在干预靶点。
  • PPAR-γ信号激动剂NAGED目前仅为体外研究证据,尚不能直接用于临床预防pCIA。

局限性

  • 研究为体外器官培养人头皮毛囊模型,结果需在体内及临床研究中进一步验证。
  • 原文摘要未报告样本量、统计方法和具体效应值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Permanent chemotherapy-induced alopecia (pCIA), for which preventive interventions remain limited, can manifest with scarring. While the underlying pathomechanisms of pCIA are unclear, depletion of epithelial hair follicle (HF) stem cells (eHFSCs) is likely to play a role. OBJECTIVES: To explore the hypothesis that, besides apoptosis, eHFSCs undergo pathological epithelial-mesenchymal transition (EMT) in pCIA, thus explaining the scarring phenotype. Furthermore, we tested whether a peroxisome proliferator-activated receptor (PPAR)-γ modulator could prevent pCIA-associated pathomechanisms. METHODS: Organ-cultured human scalp HFs were treated with the cyclophosphamide metabolite 4-hydroperoxycyclophosphamide (4-HC). Additionally, HFs were pretreated with the agonistic PPAR-γ modulator N-acetyl-GED-0507-34-Levo (NAGED), which has previously been shown to promote K15 expression and antagonize EMT in eHFSCs. RESULTS: In accordance with anticipated hair bulb cytotoxicity, dystrophy and catagen induction, 4-HC promoted apoptosis along with increased p53 expression, DNA damage and pathological EMT in keratin 15+ (K15) eHFSCs, as evidenced by decreased E-cadherin expression and the appearance of fibronectin+ and vimentin+ cells in the hair bulge. Pretreatment with NAGED protected against 4-HC-induced hair bulb cytotoxicity/dystrophy, and apoptosis, p53 upregulation and EMT in the bulge, thereby significantly preventing depletion of K15+ human eHFSCs ex vivo. CONCLUSIONS: Since a key cyclophosphamide metabolite alone suffices to damage and deplete human scalp eHFSCs by promoting apoptosis, DNA damage and EMT ex vivo, strategies to prevent pCIA need to target these pathomechanisms. Given the ability of NAGED to prevent chemotherapy-induced eHFSCs damage ex vivo, our study introduces the stimulation of PPAR-γ signalling as a novel intervention strategy for the prevention of pCIA.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Piccini I, Brunken L, Chéret J, et al. Peroxisome proliferator-activated receptor-γ signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial-mesenchymal transition. Br J Dermatol. 2021. PMID: 34496034. doi:10.1111/bjd.20745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。